Dees C, Hudson JQ, Apple A, Womeodu R, Duhart BT. Evaluation of 30-Day hospital readmissions for patients with end stage renal disease. Presented at the ACCP Annual Global Conference Meeting; October 2015; San Francisco, CA.
Finks SW (pictured above left), Brenner M, Kemp DW, Odum LE, Parker M, Parder RB, Rogers KC. Effects of carvedilol after cocaine induced chest pain. Presented at the ACCP Annual Global Conference Meeting; October 2015; San Francisco, CA.
Keough LA, Hudson JQ, Segars B, Kraus AG. Evaluation of antibiotic dosing in patients receiving sustained low‐efficiency dialysis. Presented at the ACCP Annual Global Conference Meeting; October 2015; San Francisco, CA.
Lewis S, Shelton CM. Oculogyric crisis with the use of prochlorperazine in a pediatric patient. Presented at the ACCP Annual Global Conference Meeting; October 2015; San Francisco, CA.
Marler J, Stelts S, Unzaga J, Oliphant C. Consequences of treating false positive heparin-induced thrombocytopenia. Presented at the ACCP Annual Global Conference Meeting; October 2015; San Francisco, CA.
Nelson K (pictured above center), Parker RB, Hu Z, Laizure SC. Caffeine disposition after oral inspiration (Aeroshot) compared to and energy drink. Presented at the ACCP Annual Global Conference Meeting; October 2015; San Francisco, CA.
Nishimoto A, Duhart BT, Shoop D, Canada RB, Hudson JQ. Evaluation of antihypertensive use in ESRD patients with intradialytic hypotension in the inpatient setting. Presented at the ACCP Annual Global Conference Meeting; October 2015; San Francisco, CA.
Norrid SE*, Finks SW, Parker RB, Rogers KC. Appropriate monitoring to improve amiodarone safety and tolerability. Presented at the ACCP Annual Global Conference Meeting; October 2015; San Francisco, CA.
Reedus J, Shelton CM, Sweatman T, Ostrom R, McDonough S, Phelps SJ. Assessment and survey of student pharmacists’ knowledge and perceptions of an interactive pharmacology simulation session. Presented at the ACCP Annual Global Conference Meeting; October 2015; San Francisco, CA.
Smith LN, Hudson JQ, Twilla JD. Incidence of thromboembolism and use of antithrombotic primary prophylaxis in nephrotic syndrome patients. Presented at the ACCP Annual Global Conference Meeting; October 2015; San Francisco, CA.
*Sarah Beth Norrid, PGY-2 resident at the VAMC in Memphis (pictured above right), presented the research and was awarded a travel award from the Cardiology PRN.